Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 8/20 | 0.67 |
| ▸ | P2RY2 | P41231 | 7/20 | 0.67 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.67 |
| ▸ | ST6GAL1 | P15907 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | MTOR | P42345 | 1/20 | 0.59 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.59 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.59 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11611645 | 0.92 | P2RY2 (0.75) | P2RY6P2RY2P2RY4ST6GAL1LMNA | |
| SCHEMBL29369985 | 0.87 | P2RY2 (0.84) | P2RY6P2RY2P2RY4LMNATHRB | |
| SCHEMBL9237104 | 0.86 | ST6GAL1 (0.65) | P2RY6P2RY2P2RY4ST6GAL1LMNA | |
| SCHEMBL11034833 | 0.86 | P2RY2 (0.68) | P2RY6P2RY2P2RY4ST6GAL1LMNA | |
| SCHEMBL25070751 | 0.86 | P2RY2 (0.70) | P2RY6P2RY2P2RY4ST6GAL1LMNA | |
| SCHEMBL39904 | 0.86 | P2RY2 (0.76) | P2RY6P2RY2P2RY4 | |
| SCHEMBL154172 | 0.86 | P2RY2 (0.76) | P2RY6P2RY2P2RY4 | |
| SCHEMBL532547 | 0.86 | P2RY2 (0.76) | P2RY6P2RY2P2RY4 | |
| SCHEMBL25070737 | 0.86 | P2RY2 (0.70) | P2RY6P2RY2P2RY4ST6GAL1LMNA | |
| SCHEMBL13135198 | 0.86 | P2RY2 (0.70) | P2RY6P2RY2P2RY4ST6GAL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080103110-A1 | Compounds | DRUG DISCOVERY LABORATORY AS (NO) | 2008-05-01 | — | — | US | disclosed |
| US-20080103110-A1 | Compounds | DRUG DISCOVERY LABORATORY AS (NO) | 2008-05-01 | — | — | US | disclosed |
| US-20070259889-A1 | Protein Binding Compounds | DRUG DISCOVERY LABORATORY AS (NO) | 2007-11-08 | — | — | US | disclosed |
| US-20070259889-A1 | Protein Binding Compounds | DRUG DISCOVERY LABORATORY AS (NO) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259889-A1 | Protein Binding Compounds | FABP1, FABP3, FABP2 | P2RY6 3347/4885P2RY2 4215/4885P2RY4 4431/4885 |
| US-20080103110-A1 | Compounds | ATIC, CDA, PAICS | P2RY6 481/4885P2RY2 1774/4885P2RY4 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.